CD Formulation has extensive research experience in drug formulation development and is committed to providing efficient, flexible and high-quality one-stop solutions from drug raw materials to formulation for pharmaceutical companies, research institutions and other partners. Our experienced and professional research team can provide advanced technology and high quality services to conduct personalized research, thus greatly facilitating the speed of drug research.
Small molecule drugs are chemically synthesized small molecules of active substances. Small molecule components can be made into tablets or capsules that are easily absorbed by the body. Due to their small size, small molecules can reach almost any target in the body. In addition, by virtue of their small structure and chemical composition, small molecules can generally easily penetrate cell membranes. The R&D process for chemical drugs is long, difficult and expensive as the invention and research of safe and effective new drugs is a long-term process, resulting in long lead times and significant investments in new drug development. Small molecules make up the bulk of current drugs used to treat and control conditions such as cancer, infections and depression.
Nanomedicinal applications of small molecule drugs include:
Small molecule drugs can be formulated into a variety of nanoparticle materials including liposomes, emulsions, polymeric micelles, etc. CD Formulation offers a range of services for customizing, modifying and optimizing nanoparticle materials.
As a full-service provider of drug formulations and combination products, CD Formulation has developed technologies to simplify the development of small molecule drug formulations. We provide excipients for drug formulations, design and optimization of drug carriers, as well as analysis and testing of drug molecules to speed up drug development, all from a single source.
CD Formulation's business covers all aspects of drug formulation, drug ingredients, drug development, drug testing, drug optimization, etc. We provide one-stop integrated services from pre-clinical to commercial manufacturing for our global pharmaceutical and biotech partners. In the future, we will continue to strengthen our technological barriers and enhance our R&D production and service capabilities to provide quality and diversified services to more new drug development start-ups, medium and large companies as well as pharmaceutical companies around the world.
If you have a requirement about our services, please contact us by phone or email, our colleagues will reply to you within three working days.